GSA Capital Partners’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,576
Closed -$191K 1621
2024
Q4
$191K Sell
11,576
-19,899
-63% -$328K 0.01% 1425
2024
Q3
$777K Sell
31,475
-8,087
-20% -$200K 0.06% 623
2024
Q2
$1M Sell
39,562
-4,275
-10% -$108K 0.07% 499
2024
Q1
$1.11M Sell
43,837
-14,539
-25% -$369K 0.09% 371
2023
Q4
$1.32M Buy
58,376
+6,738
+13% +$153K 0.11% 265
2023
Q3
$962K Buy
+51,638
New +$962K 0.08% 414
2023
Q2
Sell
-18,729
Closed -$538K 1493
2023
Q1
$538K Buy
+18,729
New +$538K 0.05% 663
2022
Q1
Sell
-9,717
Closed -$348K 1384
2021
Q4
$348K Sell
9,717
-9,704
-50% -$348K 0.04% 836
2021
Q3
$827K Sell
19,421
-21,434
-52% -$913K 0.08% 403
2021
Q2
$1.77M Buy
40,855
+26,385
+182% +$1.14M 0.2% 76
2021
Q1
$590K Buy
+14,470
New +$590K 0.1% 266
2020
Q2
Sell
-11,273
Closed -$326K 608
2020
Q1
$326K Buy
11,273
+1,662
+17% +$48.1K 0.08% 432
2019
Q4
$498K Buy
9,611
+21
+0.2% +$1.09K 0.06% 652
2019
Q3
$526K Sell
9,590
-416
-4% -$22.8K 0.07% 520
2019
Q2
$406K Buy
+10,006
New +$406K 0.05% 794
2019
Q1
Sell
-13,598
Closed -$457K 1404
2018
Q4
$457K Buy
13,598
+8,120
+148% +$273K 0.05% 605
2018
Q3
$231K Buy
+5,478
New +$231K 0.01% 1436
2017
Q2
Sell
-5,102
Closed -$222K 1653
2017
Q1
$222K Buy
+5,102
New +$222K 0.01% 1519
2016
Q4
Sell
-20,520
Closed -$982K 1731
2016
Q3
$982K Buy
+20,520
New +$982K 0.05% 618
2016
Q2
Sell
-12,134
Closed -$543K 1719
2016
Q1
$543K Sell
12,134
-10,005
-45% -$448K 0.03% 956
2015
Q4
$845K Buy
22,139
+2,796
+14% +$107K 0.04% 823
2015
Q3
$616K Sell
19,343
-3,200
-14% -$102K 0.03% 995
2015
Q2
$745K Buy
22,543
+5,744
+34% +$190K 0.03% 1104
2015
Q1
$692K Buy
16,799
+5,400
+47% +$222K 0.03% 1166
2014
Q4
$464K Sell
11,399
-16,823
-60% -$685K 0.03% 976
2014
Q3
$1.04M Sell
28,222
-481
-2% -$17.6K 0.05% 461
2014
Q2
$1.33M Buy
28,703
+6,555
+30% +$304K 0.06% 483
2014
Q1
$910K Buy
22,148
+1,398
+7% +$57.4K 0.06% 389
2013
Q4
$792K Buy
20,750
+1,792
+9% +$68.4K 0.06% 505
2013
Q3
$454K Buy
18,958
+7,300
+63% +$175K 0.04% 858
2013
Q2
$198K Buy
+11,658
New +$198K 0.02% 1097